Provisions in the 2017 Republican tax law allow AbbVie Inc (NYSE: ABBV ) to generate most of its sales in the U.S. while reporting virtually no income in the U.S. for tax purposes.
Data obtained by the Committee shows that AbbVie reports virtually no income in the U.S. for tax purposes.
In 2020, over 75% of AbbVie’s sales were made to American ...
Full story available on Benzinga.com